Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-100937
Filing Date
2024-04-18
Accepted
2024-04-18 17:12:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6063
2 GRAPHIC g774808g0419012141395.jpg GRAPHIC 3144
  Complete submission text file 0001193125-24-100937.txt   11546
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Filer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)